4-HO-MPMI
lucigenol
Psychedelic, Research-chemical, Tentative
A rare tryptamine derivative first synthesised by David Nichols. This drug, also known as lucigenol, has rarely been documented outside the lab. It is known to be a psychedelic similar to other psychoactive tryptamines, with a potency similar to DOI. Little else is known about the drug.
Note: As of writing this note, this substance has not been reported on dosages past 2mg. Caution should be given when dosing. The drug is near eqipotent to DOI.
Chart shows bounded mass ranges in mg. See the table for all doses.
Threshold
Light
Common
Oral
500-750ug.
750ug-1mg
1-2mg.
Onset
Duration
Oral
15m to 1
6 to 8
Euphoria, empathy, insight, brightened colour, Closed/Open eye visuals, enhanced tactile sensation, mental/physical stimulation, decreased appetite, pupil dilation, restlessness, change in perception, ego softening, sweating/chills, muscle tension, confusion, insomnia